Managing diabetes in cystic fibrosis

Diabetes, Obesity and Metabolism

Volumn 12, Issue 10, 2010, Pages 858-864

  Laguna, T A ^a   Nathan, B M ^a   Moran, A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

CFRD; Cystic fibrosis; Cystic fibrosis related diabetes; Diabetes; Insulin; Insulin resistance; Insulin sensitivity; Transplant; Treatment

Indexed keywords

CORTICOSTEROID; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; REPAGLINIDE; SULFONYLUREA; TRANSMEMBRANE CONDUCTANCE REGULATOR; TROGLITAZONE;

BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; COMORBIDITY; CYSTIC FIBROSIS; CYSTIC FIBROSIS RELATED DIABETES; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIABETOGENESIS; DIET THERAPY; DISEASE COURSE; GASTROINTESTINAL SYMPTOM; GENE MUTATION; GENETIC PREDISPOSITION; GLUCOSE BLOOD LEVEL; GROWTH; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; LACTIC ACIDOSIS; LIFE EXPECTANCY; LIVER TOXICITY; LUNG FUNCTION; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS FUNCTION; PANCREAS INSUFFICIENCY; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PATHOPHYSIOLOGY; PATIENT CARE PLANNING; PROTEIN DEGRADATION; REVIEW; WEIGHT CONTROL;

EID: 77956165007     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2010.01250.x     Document Type: Review

References (78)

1. Welsh MJ, Tsui LC, Boat TF, Beaudet AL. Cystic fibrosis. Metabolic and Molecular Basis of Inherited Disease 1995, 3799-3876. Scriver CR, Beaudet AL, Sly WS, Valle D. In:, eds., 7th edn, New York, McGraw-Hill
2. Patient Registry 2007 Annual Data Report. 2008, 1-24. Cystic Fibrosis Foundation.
3. Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2000, 162:891-895.
4. Finkelstein SM, Wielinski CL, Elliott GR. Diabetes mellitus associated with cystic fibrosis. J Pediatr 1988, 112:373-377.
5. Bismuth E, Laborde K, Taupin P. Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis. J Pediatr 2008, 152:540-545.e1.
6. Milla CE, Billings J, Moran A. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 2005, 28:2141-2144.
7. Moran A, Dunitz J, Nathan B. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 2009, 32:1626-1631.
8. Marshall BC, Butler SM, Stoddard M. Epidemiology of cystic fibrosis-related diabetes. J Pediatr 2005, 146:681-687.
9. Casas L, Berry DR, Logan K. Cystic fibrosis related diabetes in an extremely young patient. J Cyst Fibros 2007, 6:247-249.
10. Gelfand IM, Eugster EA, Haddad NG. Infancy-onset cystic fibrosis-related diabetes. Diabetes Care 2005, 28:2593-2594.
11. Lombardi F, Raia V, Spagnuolo MI. Diabetes in an infant with cystic fibrosis. Pediatr Diabetes 2004, 5:199-201.
12. Siahanidou T, Mandyla H, Doudounakis S. Hyperglycaemia and insulinopenia in a neonate with cystic fibrosis. Acta Paediatr 2005, 94:1837-1840.
13. Gaskin KJ, Durie PR, Corey M. Evidence for a primary defect of pancreatic HCO3-secretion in cystic fibrosis. Pediatr Res 1982, 16:554-557.
14. Kopelman H, Corey M, Gaskin K. Impaired chloride secretion, as well as bicarbonate secretion, underlies the fluid secretory defect in the cystic fibrosis pancreas. Gastroenterology 1988, 95:349-355.
15. Soejima K, Landing BH. Pancreatic islets in older patients with cystic fibrosis with and without diabetes mellitus: morphometric and immunocytologic studies. Pediatr Pathol 1986, 6:25-46.
16. Couce M, O'Brien TD, Moran A. Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis. J Clin Endocrinol Metab 1996, 81:1267-1272.
17. Iannucci A, Mukai K, Johnson D. Endocrine pancreas in cystic fibrosis: an immunohistochemical study. Hum Pathol 1984, 15:278-284.
18. Lohr M, Goertchen P, Nizze H. Cystic fibrosis associated islet changes may provide a basis for diabetes. An immunocytochemical and morphometrical study. Virchows Arch A Pathol Anat Histopathol 1989, 414:179-185.
19. Janson J, Ashley RH, Harrison D. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 1999, 48:491-498.
20. Kahn SE, Carr DB, Faulenbach MV. An examination of beta-cell function measures and their potential use for estimating beta-cell mass. Diabetes Obes Metab 2008, 10((Suppl. 4)):63-76.
21. Cucinotta D, De Luca F, Arrigo T. First-phase insulin response to intravenous glucose in cystic fibrosis patients with different degrees of glucose tolerance. J Pediatr Endocrinol 1994, 7:13-17.
22. De Schepper J, Hachimi-Idrissi S, Smitz J. First-phase insulin release in adult cystic fibrosis patients: correlation with clinical and biological parameters. Horm Res 1992, 38:260-263.
23. Lippe BM, Sperling MA, Dooley RR. Pancreatic alpha and beta cell functions in cystic fibrosis. J Pediatr 1977, 90:751-755.
24. Arrigo T, Cucinotta D, Conti Nibali S. Longitudinal evaluation of glucose tolerance and insulin secretion in non-diabetic children and adolescents with cystic fibrosis: results of a two-year follow-up. Acta Paediatr 1993, 82:249-253.
25. Lanng S, Thorsteinsson B, Roder ME. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Acta Endocrinol (Copenh) 1993, 128:207-214.
26. Moran A, Diem P, Klein DJ. Pancreatic endocrine function in cystic fibrosis. J Pediatr 1991, 118:715-723.
27. Cucinotta D, Conti Nibali S, Arrigo T. Beta cell function, peripheral sensitivity to insulin and islet cell autoimmunity in cystic fibrosis patients with normal glucose tolerance. Horm Res 1990, 34:33-38.
28. Cucinotta D, Arrigo T, De Luca F. Metabolic and clinical events preceding diabetes mellitus onset in cystic fibrosis. Eur J Endocrinol 1996, 134:731-736.
29. De Luca F, Arrigo T, Di Benedetto A. Four-year follow-up of glucose tolerance and beta-cell function in nondiabetic cystic fibrosis patients. Horm Res 1995, 44:45-50.
30. Lombardo F, De Luca F, Rosano M. Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia. Eur J Endocrinol 2003, 149:53-59.
31. Costa M, Potvin S, Hammana I. Increased glucose excursion in cystic fibrosis and its association with a worse clinical status. J Cyst Fibros 2007, 6:376-383.
32. Holl RW, Wolf A, Thon A. Insulin resistance with altered secretory kinetics and reduced proinsulin in cystic fibrosis patients. J Pediatr Gastroenterol Nutr 1997, 25:188-193.
33. Swartz LM, Laffel LM. A teenage girl with cystic fibrosis-related diabetes, diabetic ketoacidosis, and cerebral edema. Pediatr Diabetes 2008, 9:426-430.
34. Ahmad T, Nelson R, Taylor R. Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis. Metabolism 1994, 43:163-167.
35. Cucinotta D, De Luca F, Gigante A. No changes of insulin sensitivity in cystic fibrosis patients with different degrees of glucose tolerance: an epidemiological and longitudinal study. Eur J Endocrinol 1994, 130:253-258.
36. Lanng S, Thorsteinsson B, Roder ME. Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance. Clin Endocrinol (Oxf) 1994, 41:217-223.
37. Moran A, Pyzdrowski KL, Weinreb J. Insulin sensitivity in cystic fibrosis. Diabetes 1994, 43:1020-1026.
38. Hardin DS, LeBlanc A, Lukenbough S. Insulin resistance is associated with decreased clinical status in cystic fibrosis. J Pediatr 1997, 130:948-956.
39. Hardin DS, Leblanc A, Marshall G. Mechanisms of insulin resistance in cystic fibrosis. Am J Physiol Endocrinol Metab 2001, 281:E1022-E1028.
40. Koch C, Cuppens H, Rainisio M. European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol 2001, 31:1-12.
41. Lanng S, Thorsteinsson B, Pociot F. Diabetes mellitus in cystic fibrosis: genetic and immunological markers. Acta Paediatr 1993, 82:150-154.
42. Minicucci L, Cotellessa M, Pittaluga L. Beta-cell autoantibodies and diabetes mellitus family history in cystic fibrosis. J Pediatr Endocrinol Metab 2005, 18:755-760.
43. De Luca F, Arrigo T, Conti Nibali S. Insulin secretion, glycosylated haemoglobin and islet cell antibodies in cystic fibrosis children and adolescents with different degrees of glucose tolerance. Horm Metab Res 1991, 23:495-498.
44. Atlas AB, Finegold DN, Becker D. Diabetic ketoacidosis in cystic fibrosis. Am J Dis Child 1992, 146:1457-1458.
45. Blackman SM, Hsu S, Ritter SE. A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis. Diabetologia 2009, 52:1858-1865.
46. Blackman SM, Hsu S, Vanscoy LL. Genetic modifiers play a substantial role in diabetes complicating cystic fibrosis. J Clin Endocrinol Metab 2009, 94:1302-1309.
47. Derbel S, Doumaguet C, Hubert D. Calpain 10 and development of diabetes mellitus in cystic fibrosis. J Cyst Fibros 2006, 5:47-51.
48. Koch C, Rainisio M, Madessani U. Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 2001, 32:343-350.
49. O'Riordan SMP, Robinson PD, Donaghue KC. Management of cystic fibrosis related diabetes in children and adolescents. Pediatr Diabetes 2009, 10(Suppl. 12):43-50.
50. Yung B, Landers A, Mathalone B. Diabetic retinopathy in adult patients with cystic fibrosis-related diabetes. Respir Med 1998, 92:871-872.
51. Clinical practice recommendations. Diabetes Care 2010, 33:S1-S2. American Diabetes Association
52. Schwarzenberg SJ, Thomas W, Olsen TW. Microvascular complications in cystic fibrosis-related diabetes. Diabetes Care 2007, 30:1056-1061.
53. Godbout A, Hammana I, Potvin S. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes. Diabetes Metab 2008, 34:568-573.
54. Ode KL, Frohnert B, Laguna T. Oral glucose tolerance testing in children with cystic fibrosis. Pediatr Diabetes 2010 [Epub ahead of print].
55. Moran A, Hardin D, Rodman D. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract 1999, 45:61-73.
56. Austin MM. Diabetes educators: partners in diabetes care and management. Endocr Pract 2006, 12((Suppl. 1)):138-141.
57. Aschner P, LaSalle J, McGill M. The team approach to diabetes management: partnering with patients. Int J Clin Pract Suppl 2007, (157):22-30.
58. Lanng S, Thorsteinsson B, Nerup J. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr 1994, 83:849-853.
59. Mohan K, Israel KL, Miller H. Long-term effect of insulin treatment in cystic fibrosis-related diabetes. Respiration 2008, 76:181-186.
60. Rolon MA, Benali K, Munck A. Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr 2001, 90:860-867.
61. Grover P, Thomas W, Moran A. Glargine versus NPH insulin in cystic fibrosis related diabetes. J Cyst Fibros 2008, 7:134-136.
62. Hardin DS, Rice J, Rice M. Use of the insulin pump in treat cystic fibrosis related diabetes. J Cyst Fibros 2009, 8:174-178.
63. Moran A, Pekow P, Grover P. Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial. Diabetes Care 2009, 32:1783-1788.
64. Culler FL, McKean LP, Buchanan CN. Glipizide treatment of patients with cystic fibrosis and impaired glucose tolerance. J Pediatr Gastroenterol Nutr 1994, 18:375-378.
65. Onady GM, Stolfi A. Insulin and oral agents for managing cystic fibrosis-related diabetes. Cochrane Database Syst Rev 2005, (3):CD004730.
66. Moran A, Phillips J, Milla C. Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes. Diabetes Care 2001, 24:1706-1710.
67. Rosenecker J, Eichler I, Barmeier H. Diabetes mellitus and cystic fibrosis: comparison of clinical parameters in patients treated with insulin versus oral glucose-lowering agents. Pediatr Pulmonol 2001, 32:351-355.
68. Kentrup H, Bongers H, Spengler M. Efficacy and safety of acarbose in patients with cystic fibrosis and impaired glucose tolerance. Eur J Pediatr 1999, 158:455-459.
69. Silvestre J, Carvalho S, Mendes V. Metformin-induced lactic acidosis: a case series. J Med Case Reports 2007, 1:126.
70. Scheen AJ. Thiazolidinediones and liver toxicity. Diabetes Metab 2001, 27:305-313.
71. Sheppard DN, Welsh MJ. Effect of ATP-sensitive K+ channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents. J Gen Physiol 1992, 100:573-591.
72. Stallings VA, Stark LJ, Robinson KA. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc 2008, 108:832-839.
73. Elder DA, Wooldridge JL, Dolan LM. Glucose tolerance, insulin secretion, and insulin sensitivity in children and adolescents with cystic fibrosis and no prior history of diabetes. J Pediatr 2007, 151:653-658.
74. Solomon MP, Wilson DC, Corey M. Glucose intolerance in children with cystic fibrosis. J Pediatr 2003, 142:128-132.
75. Nousia-Arvanitakis S, Galli-Tsinopoulou A, Dracoulacos D. Islet autoantibodies and insulin dependent diabetes mellitus in cystic fibrosis. J Pediatr Endocrinol Metab 2000, 13:319-324.
76. Fridell JA, Wozniak TC, Powelson JA. Simultaneous bilateral lung and pancreas transplantation in recipient with cystic fibrosis. Transplant Proc 2008, 40:494-497.
77. Fridell JA, Wozniak TC, Reynolds JM. Bilateral sequential lung and simultaneous pancreas transplant: a new approach for the recipient with cystic fibrosis. J Cyst Fibros 2008, 7:280-284.
78. Cretin N, Buhler L, Fournier B. Results of human islet allotransplantation in cystic fibrosis and type I diabetic patients. Transplant Proc 1998, 30:315-316.